1. Anti-addiction groups call for resignation of FDA chief over opioid policies.
2. DEA announces drug-return program in hopes of controlling opioids, other prescription meds
3. Hydrocodone rules get tougher as DEA ups to Schedule II
More articles on accreditation:
3 recent ASC checklists
Ebola checklist for outpatient facilities
Patient safety top of FDA’s new regulatory priorities
